GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
76 hedge funds and large institutions have $88.1M invested in Aevi Genomic Medicine Inc in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $91.2M → $88.1M (-$3.13M)
Holders
76
Holding in Top 10
1
Calls
$6.58M
Puts
$337K
Top Buyers
| 1 | +$1.88M | |
| 2 | +$734K | |
| 3 | +$384K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$380K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$357K |
Top Sellers
| 1 | -$1.55M | |
| 2 | -$688K | |
| 3 | -$223K | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$203K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$84K |